Scott Neumann, DO
Family Medicine · Plano, TXNPI 1114981461
Payments from drug & device makers
Across 157 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$370
- AstraZeneca$274
- Takeda Pharmaceuticals U.S.A., Inc.$265
- Amgen$225
- AbbVie$204
- Exact Sciences$125
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,677100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $370 |
| AstraZeneca | 17 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $265 |
| Amgen | 7 | $225 |
| AbbVie(2 entities) | 14 | $204 |
| Exact Sciences | 6 | $125 |
| GSK | 8 | $123 |
| Medtronic(2 entities) | 5 | $118 |
| Amarin Pharma, Inc. | 7 | $108 |
| Merck | 8 | $106 |
| Sanofi-aventis U.S. LLC | 5 | $94 |
| Boehringer Ingelheim | 5 | $90 |
| Daiichi Sankyo Inc. | 6 | $86 |
| Astellas Pharma US Inc | 4 | $81 |
| Dynavax Technologies Corporation | 3 | $60 |
| Shire North American Group Inc | 4 | $58 |
| Si-bone, Inc. | 2 | $57 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Abbott | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$125
How this compares
$2,677 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tresiba Flextouch U-200Insulin Degludec | 11 | $9,962 |
| Atorvastatin Calcium | 174 | $1,146 |
| Ezetimibe | 36 | $904 |
| Pravastatin Sodium | 34 | $537 |
| Metformin Hcl ErMetformin Hcl | 63 | $525 |
| Levothyroxine Sodium | 81 | $518 |
| Metoprolol Succinate | 33 | $451 |
| Pantoprazole Sodium | 42 | $438 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 38 | $409 |
| Tamsulosin Hcl | 29 | $306 |
| Carvedilol | 21 | $285 |
| Gabapentin | 22 | $284 |
| Lisinopril | 63 | $256 |
| Meloxicam | 64 | $256 |
| Amlodipine Besylate | 57 | $218 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plano
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.